Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cantor Fitzgerald
Cerilliant
QuintilesIMS
Julphar
Johnson and Johnson
US Department of Justice
Argus Health
Baxter

Generated: May 20, 2018

DrugPatentWatch Database Preview

BEROCCA PN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Berocca Pn patents expire, and what generic alternatives are available?

Berocca Pn is a drug marketed by Roche and is included in one NDA.

The generic ingredient in BEROCCA PN is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin e profile page.
Summary for BEROCCA PN
You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A PALMITATE','VITAMIN E') AND hsdb_dru' at line 1
US Patents:0
Applicants:1
NDAs:1